-
Kane saves England as USA, Belgium reach last 16
-
South Korean school baseball team suspended over 'Tank Day' chants
-
Budding chefs cook up new career at China's BBQ academy
-
Ceuzany, Cape Verde's golden voice with volcanic emotion
-
One stitch at a time: Artist's mission to recreate the Bayeux Tapestry
-
Balogun scores and sees red as US beat Bosnia 2-0
-
Deadly Russian barrage pounds Ukraine capital
-
EU top court to rule on record 4.1 bn euro Google fine
-
Belgium coach salutes Tielemans after World Cup rescue act
-
'Job forever': trade schools are all the rage in the AI era
-
Cracking open a can of cannabis -- America's new pastime (for now)
-
Celtics reportedly trading Brown to Sixers in NBA blockbuster
-
Russia strikes Ukraine capital with missiles and drones, wounds five
-
Kane saves England after DR Congo scare; Belgium comeback stuns Senegal
-
Belgium late show floors Senegal at World Cup
-
Celtics to trade Jaylen Brown to 76ers for Paul George: report
-
Harry Kane: England's World Cup saviour
-
Streamex is making digital gold accessible
-
US actor Danny Glover says he has Alzheimer's
-
Mixed US auto sales in Q2 amid high gas prices
-
Trump sees progress as US, Iran hold Qatar talks
-
Pistons forward Harris reportedly headed to Spurs
-
Djokovic, Sinner into Wimbledon third round, Andreeva stunned
-
Jovial Djokovic dismantles Tsitsipas to reach Wimbledon third round
-
Spurs agree club record £100 mn move for Newcastle's Tonali - reports
-
US stocks retreat to open Q3 ahead of June jobs data
-
Rain has final say in 1st England-India T20 as Sooryavanshi still awaits debut
-
'Gus' the T. rex presented in New York ahead of auction
-
England refused to accept defeat in 'beautiful' DR Congo win, says Tuchel
-
Kane saves England after DR Congo scare; US eye last 16
-
'Let the dogs in': Sabalenka wants Wimbledon to lift ban
-
Catholic society defies Vatican by consecrating new bishops
-
Oppressive heat broils US during World Cup, July Fourth
-
New York prepares for Taylor Swift-Travis Kelce wedding
-
Can anyone stop France at the World Cup?
-
Pair climb to top of Empire State Building for apparent proposal
-
Sinner, Sabalenka into Wimbledon third round, Andreeva stunned
-
French Open champ Andreeva stunned by Krejcikova at Wimbledon
-
England have 'hero moments', says Kane after double downs DR Congo
-
Kane rescues England after DR Congo scare; US eye last 16
-
努莎·奧貝爾:為市民實施時速10公里限速,波茨坦的「坑洞政策」——是漠不關心還是無能為力?
-
Kane rescues England from DR Congo calamity to reach World Cup last 16
-
US refuses to extend North America trade pact in current form
-
'Iran, Iran!' Iranian World Cup squad serenaded on return home
-
Mixed US auto sales in 2nd quarter amid high gas prices
-
Pereira 'taken by complete surprise' as Forest let boss go
-
Swiatek, Zverev hoping to lay down Wimbledon markers
-
Нуша Аубель: «Скорость 10» для жителей: политика Потсдама в отношении выбоин — безразличие или некомпетентность?
-
Spray-painted letters spell tragedy for Venezuela quake victims
-
Rufus the hawk patrolling Wimbledon tennis club
Repeat Covid infections increase risk of health problems: study
People who have had Covid more than once are two or three times more likely to have a range of serious health problems than those who have only had it once, the first major study on the subject said Thursday.
Multiple infections have surged as the pandemic rumbles on and the virus mutates into new strains, but the long-term health effects of reinfection have not been clear.
The US researchers said their new study published in the Nature Medicine journal was the first to look at how reinfection increases the risk of health problems from acute cases as well as long Covid.
The researchers analysed the anonymous medical records of 5.8 million people in the US Department of Veterans Affairs' national healthcare database.
More than 443,000 had tested positive for Covid at least once between March 1, 2020 and April this year.
Nearly 41,000 of that group had Covid more than once. Over 93 percent had a total of two infections, while six percent had three and nearly one percent had four.
The other 5.3 million never contracted Covid.
When the researchers compared the health outcomes of the different groups, they found that "people who got reinfected have an increased risk of all sorts of adverse health problems," Ziyad Al-Aly, an epidemiologist at Washington University in St Louis and the study's senior author, told AFP.
People with repeat infections were twice as likely to die prematurely and three times more likely to be hospitalised with illness than those who had not been reinfected, the study found.
Heart and lung problems were more than three times more common for people who had been reinfected.
Reinfection also contributes to brain conditions, kidney disease and diabetes, the study said.
And the risk of such problems could increase with each infection, it suggested.
- 'Worrisome' -
Al-Aly warned that this means that continuous reinfections "would likely elevate the burden of disease in the population".
Ahead of a feared Covid spike during the holiday season, he called on people to wear masks to protect themselves.
He also urged authorities to do more to stop Covid circulating.
"The reason reinfection is happening is that our current vaccine strategy does not block transmission," he said.
"I think reinfections will continue to happen until we have vaccines that block transmission, offer more durable protection, and are variant proof."
The authors said the limitations of the study included that most of the veteran participants were older white males.
When the study was released as a preprint in June, US expert Eric Topol described the findings as "worrisome".
In a Substack post, Topol pointed out that reinfections became "much more common" after April, when the study's time frame ended, due to new, more transmissible Omicron variants.
In more positive news, earlier this week Al-Aly published a pre-print study, which has not been peer-reviewed, which found that people who took Pfizer's drug Paxlovid within five days of testing positive had a reduced risk of getting long Covid.
J.Fankhauser--BTB